Antipsychotic Medications

Looking at dementia beyond drugs and disease

Looking at dementia beyond drugs and disease

The emerging literature on "nonpharmacological interventions" has not succeeded in providing long-term solutions for many people, such that expressions of need continue to recur on a regular basis.

Long-term care providers achieved 15% antipsychotic reduction goal, CMS announces

Long-term care providers achieved 15% antipsychotic reduction goal, CMS announces

By

Long-term care facilities have reduced antipsychotic medication use by more than 15% through a large-scale initiative, according to a new report from the Centers for Medicare & Medicaid Services. That means it's time to set a more ambitious goal, a subgroup says.

Antidepressant Celexa could be an alternative to antipsychotic medication for Alzheimer's, study suggests

By

An antidepressant drug could help relieve agitation symptoms of Alzheimer's disease, reducing reliance on antipsychotic medications, according to recently published study results.

Nursing home quality could improve with better palliative care interventions, large-scale trial shows

Nursing home quality could improve with better palliative care interventions, large-scale trial shows

By

By following practices that are common in home-based hospice care, nursing homes can improve the comfort and dignity of residents who are dying, according to new study results.

Proposed Medicare rules would tighten CMS oversight of nursing home prescriptions

Proposed Medicare rules would tighten CMS oversight of nursing home prescriptions

By

In light of reports that Medicare Part D prescribing practices are endangering seniors — many of them in long-term care facilities — the Centers for Medicare & Medicaid Services has issued a proposed rule that would give the agency more power to oversee and control the prescription drug program.

Ask the legal expert ... about antipsychotic medication liability

Ask the legal expert ... about antipsychotic medication liability

By

I'm an administrator who's read all of this stuff about overuse of antipsychotics on long-term care residents. I like and trust my director of nursing, medical director and clinical staff — to a degree, that is — but what can I do to REALLY know that we're not overusing this stuff, and would not be liable for some sort of adverse regulatory or court findings?

Caregivers should prepare for some residents to 'get worse' during antipsychotic drawdown, CMS officials urge

By

Leaders in long-term care facilities should take steps to ensure that residents with dementia are not unnecessarily put back on antipsychotic medications, according to officials who spoke on a call with providers Monday.

AMDA issues list of competencies for long-term care physicians

AMDA issues list of competencies for long-term care physicians

By

Doctors practicing in long-term care settings should hone certain skills identified by leading stakeholders in order to produce higher quality outcomes, according to a prominent physician association. The list of competencies for physicians in post-acute and long-term care medicine was released Monday by AMDA-Dedicated to Long-Term Care (formerly the American Medical Directors Association).

Providers can cheer widespread quality improvement, but infection control poses a challenge: AHCA report

By

More long-term care facilities are earning top marks in national quality ratings, but providers may need increased focus on infection control, according to the American Health Care Association's 2013 Quality Report. Between 2011 and 2012, providers improved "in almost all the quality measures generally used," the report states.

Fewer residents given antipsychotics: CMS

Fewer residents given antipsychotics: CMS

By

Fewer residents with dementia are being prescribed antipsychotic medications, according to new figures heralded by the government and the nation's largest nursing home association.

Biggest losers

Biggest losers

By

Providers reveal strategies for reducing unneccessary antipsychotics use for residents with dementia, and meeting industry-wide medication reduction goals

Pain management difficult for stoic residents, those with dementia, study finds

By

Effective pain management in long-term care is hampered by residents' attitudes and caregivers' misinterpretation of behaviors, according to newly published research in the journal Nursing Older People.

AMDA joins campaign to reduce unnecessary tests

The American Medical Directors Association has joined with ABIM Foundation's Choosing Wisely® campaign to promote discussions between healthcare providers and patients for what medical tests or procedures may be unnecessary.

CMS and AHCA: Providers zeroing in on antipsychotic reduction target

CMS and AHCA: Providers zeroing in on antipsychotic reduction target

By

Nursing homes have made strides toward reducing antipsychotic medication use among residents with dementia, according to new figures from the Centers for Medicare & Medicaid Services and the American Health Care Association/National Center for Assisted Living.

Common antipsychotic fails as effective delirium treatment, study finds

By

Haloperidol, a common antipsychotic, is no more effective than a placebo in treating delirium in critically ill patients, according to a new study.

AlixaRx continues to expand; parent gives capital infusion

AlixaRx continues to expand; parent gives capital infusion

By

A pharmacy company on track to serve more than 400 healthcare facilities has received a $100 million investment from Fillmore Capital Partners, which owns Golden Living.